We would like to announce that PRISM BioLab and Eli Lilly and Company have mutually agreed to terminate the collaboration and licensing agreement previously established between the two companies.

For more details, please see the full announcement below:
https://contents.xj-storage.jp/xcontents/AS09340/e4067309/8794/4b19/8225/2fb73b3fca54/140120250728521212.pdf